{"count":4617,"next":"https://www.mitotox.org/api/records/list?format=json&page=47","previous":"https://www.mitotox.org/api/records/list?format=json&page=45","results":[{"rec_id":"RC04944","func":"F020403","targ":null,"compound":"D0089: Nefazodone","paper":"326","func_act":"","targ_act":"","dose":"10","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04945","func":"F020403","targ":null,"compound":"D0374: Niclosamide","paper":"326","func_act":"","targ_act":"","dose":"1.4","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04946","func":"F020403","targ":null,"compound":"D0377: Nitrofurantoin","paper":"326","func_act":"","targ_act":"","dose":"","time":"","method":"Assessment of the function of individual mitochondrial complexes  using Agilent Seahorse XFe24","species":"","animal_model":"permeabilized LUHMES cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04947","func":"F020403","targ":"T019","compound":"D0289: Oligomycin","paper":"326","func_act":"","targ_act":"","dose":"8.7","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04948","func":"F020403","targ":null,"compound":"D0097: Phenformin","paper":"326","func_act":"","targ_act":"","dose":"27","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04949","func":"F020403","targ":null,"compound":"D1470: Phenylglyoxal hydrate","paper":"326","func_act":"","targ_act":"","dose":"1.3","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04950","func":"F020403","targ":"T004","compound":"D1055: picoxystrobin","paper":"326","func_act":"","targ_act":"inhibit","dose":"50µM ","time":"","method":"Assessment of the function of individual mitochondrial complexes  using Agilent Seahorse XFe24","species":"","animal_model":"permeabilized LUHMES cells","criteria":"","result":true},{"rec_id":"RC04951","func":"F020403","targ":"T004","compound":"D1073: pyraclostrobin","paper":"326","func_act":"","targ_act":"inhibit","dose":"50µM ","time":"","method":"Assessment of the function of individual mitochondrial complexes  using Agilent Seahorse XFe24","species":"","animal_model":"permeabilized LUHMES cells","criteria":"","result":true},{"rec_id":"RC04952","func":"F020403","targ":null,"compound":"D0297: Pyridaben","paper":"326","func_act":"","targ_act":"","dose":"75000","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04953","func":"F020403","targ":null,"compound":"D1465: Pyrimidifen","paper":"326","func_act":"","targ_act":"","dose":"10000","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04954","func":"F020403","targ":"T001","compound":"D0229: Rotenone","paper":"326","func_act":"","targ_act":"","dose":"51","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04955","func":"F020403","targ":null,"compound":"D1469: Salinomycin","paper":"326","func_act":"","targ_act":"","dose":"3.7","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04956","func":"F020403","targ":"T005","compound":"D0232: Sodium Azide","paper":"326","func_act":"","targ_act":"","dose":"11","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04957","func":"F020403","targ":null,"compound":"D0163: Cyanide","paper":"326","func_act":"","targ_act":"","dose":"5.2","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04958","func":"F020403","targ":"T001","compound":"D0153: Tebufenpyrad","paper":"326","func_act":"","targ_act":"","dose":"2700","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04959","func":"F020403","targ":"T002","compound":"D1466: Thifluzamide","paper":"326","func_act":"","targ_act":"","dose":"2","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04961","func":"F020403","targ":null,"compound":"D1152: triphenyltin hydroxide","paper":"326","func_act":"","targ_act":"","dose":"0.9","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04962","func":"F020403","targ":null,"compound":"D0303: UK-5099","paper":"326","func_act":"","targ_act":"","dose":"1.7","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04963","func":"F020403","targ":null,"compound":"D0270: Valinomycin","paper":"326","func_act":"","targ_act":"","dose":"1","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04964","func":"F010401","targ":null,"compound":"D0124: Troglitazone","paper":"331","func_act":"induce","targ_act":"","dose":"10–75 μM","time":"","method":"Mitochondrial swelling as the indicator of mitochondrial permeability transition (MPT) was estimated from the decrease in absorbance at 540 nm.","species":"male CD-1 mice","animal_model":"isolated liver mitochondria","criteria":"","result":true},{"rec_id":"RC04965","func":"F010401","targ":null,"compound":"D0026: Ciglitazone","paper":"331","func_act":"induce","targ_act":"","dose":"10–75 μM","time":"","method":"Mitochondrial swelling as the indicator of mitochondrial permeability transition (MPT) was estimated from the decrease in absorbance at 540 nm.","species":"male CD-1 mice","animal_model":"isolated liver mitochondria","criteria":"","result":true},{"rec_id":"RC04966","func":"F010401","targ":null,"compound":"D0108: Rosiglitazone","paper":"331","func_act":"induce","targ_act":"","dose":"50 μM","time":"","method":"Mitochondrial swelling as the indicator of mitochondrial permeability transition (MPT) was estimated from the decrease in absorbance at 540 nm.","species":"male CD-1 mice","animal_model":"isolated liver mitochondria","criteria":"","result":false},{"rec_id":"RC04967","func":"F010401","targ":null,"compound":"D0098: Pioglitazone","paper":"331","func_act":"induce","targ_act":"","dose":"50 μM","time":"","method":"Mitochondrial swelling as the indicator of mitochondrial permeability transition (MPT) was estimated from the decrease in absorbance at 540 nm.","species":"male CD-1 mice","animal_model":"isolated liver mitochondria","criteria":"","result":false},{"rec_id":"RC04968","func":"F01","targ":null,"compound":"D0124: Troglitazone","paper":"331","func_act":"decrease","targ_act":"","dose":"10–50 μM","time":"3min","method":"The electrical transmembrane potential of mitochondria was monitored spectrophotometrically with the cationic dye, rhodamine 123, and monitored at the 505/535 nm.","species":"male CD-1 mice","animal_model":"isolated liver mitochondria","criteria":"p < 0.05, significantly different from the control ","result":true},{"rec_id":"RC04969","func":"F01","targ":null,"compound":"D0026: Ciglitazone","paper":"331","func_act":"decrease","targ_act":"","dose":"10–50 μM","time":"3min","method":"The electrical transmembrane potential of mitochondria was monitored spectrophotometrically with the cationic dye, rhodamine 123, and monitored at the 505/535 nm.","species":"male CD-1 mice","animal_model":"isolated liver mitochondria","criteria":"p < 0.05, significantly different from the control ","result":true},{"rec_id":"RC04970","func":"F01","targ":null,"compound":"D0108: Rosiglitazone","paper":"331","func_act":"decrease","targ_act":"","dose":"10–50 μM","time":"3min","method":"The electrical transmembrane potential of mitochondria was monitored spectrophotometrically with the cationic dye, rhodamine 123, and monitored at the 505/535 nm.","species":"male CD-1 mice","animal_model":"isolated liver mitochondria","criteria":"","result":false},{"rec_id":"RC04971","func":"F01","targ":null,"compound":"D0098: Pioglitazone","paper":"331","func_act":"decrease","targ_act":"","dose":"10–25 μM","time":"3min","method":"The electrical transmembrane potential of mitochondria was monitored spectrophotometrically with the cationic dye, rhodamine 123, and monitored at the 505/535 nm.","species":"male CD-1 mice","animal_model":"isolated liver mitochondria","criteria":"","result":false},{"rec_id":"RC04972","func":"F01","targ":null,"compound":"D0098: Pioglitazone","paper":"331","func_act":"decrease","targ_act":"","dose":"50 μM","time":"3min","method":"The electrical transmembrane potential of mitochondria was monitored spectrophotometrically with the cationic dye, rhodamine 123, and monitored at the 505/535 nm.","species":"male CD-1 mice","animal_model":"isolated liver mitochondria","criteria":"p < 0.05, significantly different from the control ","result":true},{"rec_id":"RC04973","func":"F02110302","targ":null,"compound":"D0124: Troglitazone","paper":"331","func_act":"decrease","targ_act":"","dose":"50 μM","time":"","method":"Assessment of mitochondrial Ca2+ efflux with arsenazo III at 675/685 nm.","species":"male CD-1 mice","animal_model":"isolated liver mitochondria","criteria":"","result":true},{"rec_id":"RC04974","func":"F02110302","targ":null,"compound":"D0026: Ciglitazone","paper":"331","func_act":"decrease","targ_act":"","dose":"50 μM","time":"","method":"Assessment of mitochondrial Ca2+ efflux with arsenazo III at 675/685 nm.","species":"male CD-1 mice","animal_model":"isolated liver mitochondria","criteria":"","result":true},{"rec_id":"RC04975","func":"F02110302","targ":null,"compound":"D0108: Rosiglitazone","paper":"331","func_act":"decrease","targ_act":"","dose":"50 μM","time":"","method":"Assessment of mitochondrial Ca2+ efflux with arsenazo III at 675/685 nm.","species":"male CD-1 mice","animal_model":"isolated liver mitochondria","criteria":"","result":false},{"rec_id":"RC04976","func":"F02110302","targ":null,"compound":"D0098: Pioglitazone","paper":"331","func_act":"decrease","targ_act":"","dose":"50 μM","time":"","method":"Assessment of mitochondrial Ca2+ efflux with arsenazo III at 675/685 nm.","species":"male CD-1 mice","animal_model":"isolated liver mitochondria","criteria":"","result":false},{"rec_id":"RC04977","func":"F010401","targ":null,"compound":"D0124: Troglitazone","paper":"225","func_act":"induce","targ_act":"","dose":"10 µM","time":"6hr","method":"Co2+-calcein assays; MPT pore opening was determined by measuring intensity of calcein fluorescence in the mitochondria quenched by cobalt and normalizing cell number of hoechst33342.","species":"ZDF fa/fa rat vs ZDF lean rat","animal_model":"hepatocytes","criteria":" significantly different from ZDF lean rats (p < 0.05) ","result":true},{"rec_id":"RC04978","func":"F0303","targ":null,"compound":"D0124: Troglitazone","paper":"225","func_act":"induce","targ_act":"","dose":"10 µM","time":"","method":"Mitochondrial swelling as an indicator of MPT was determined by the decrease in absorbance at 540 nm on a UV-2550 spectrophotometer.","species":"ZDF fa/fa rat vs ZDF lean rat","animal_model":"isolated liver mitochondria","criteria":" significantly different from ZDF lean rats (p < 0.05) ","result":true},{"rec_id":"RC04979","func":"F01","targ":null,"compound":"D0124: Troglitazone","paper":"225","func_act":"decrease","targ_act":"","dose":"10-50 µM","time":"","method":"The transmembrane potential of the mitochondria was monitored spectrophotometrically using rhodamine-123.","species":"ZDF fa/fa rat & ZDF lean rat","animal_model":"isolated liver mitochondria","criteria":"significantly different from control group (p < 0.05)","result":true},{"rec_id":"RC04980","func":"F01","targ":null,"compound":"D0098: Pioglitazone","paper":"225","func_act":"decrease","targ_act":"","dose":"25-50 µM","time":"","method":"The transmembrane potential of the mitochondria was monitored spectrophotometrically using rhodamine-123.","species":"ZDF fa/fa rat & ZDF lean rat","animal_model":"isolated liver mitochondria","criteria":"significantly different from control group (p < 0.05)","result":true},{"rec_id":"RC04981","func":"F01","targ":null,"compound":"D0097: Phenformin","paper":"225","func_act":"decrease","targ_act":"","dose":"100-300 μM","time":"","method":"The transmembrane potential of the mitochondria was monitored spectrophotometrically using rhodamine-123.","species":"ZDF fa/fa rat & ZDF lean rat","animal_model":"isolated liver mitochondria","criteria":"significantly different from control group (p < 0.05)","result":true},{"rec_id":"RC04982","func":"F02010201","targ":null,"compound":"D0124: Troglitazone","paper":"225","func_act":"decrease","targ_act":"","dose":"10-50 μM","time":"","method":"OCR and measured using a fluorescent oxygen probe (Presens)","species":"ZDF fa/fa rat & ZDF lean rat","animal_model":"isolated liver mitochondria","criteria":"significantly different from control (p < 0.05)","result":true},{"rec_id":"RC04983","func":"F02010201","targ":null,"compound":"D0124: Troglitazone","paper":"225","func_act":"","targ_act":"","dose":"10-50 μM","time":"","method":"OCR and measured using a fluorescent oxygen probe (Presens)","species":"ZDF fa/fa rat & ZDF lean rat","animal_model":"isolated liver mitochondria","criteria":"","result":false},{"rec_id":"RC04984","func":"F02010201","targ":null,"compound":"D0098: Pioglitazone","paper":"225","func_act":"decrease","targ_act":"","dose":"25-50 μM","time":"","method":"OCR and measured using a fluorescent oxygen probe (Presens)","species":"ZDF fa/fa rat & ZDF lean rat","animal_model":"isolated liver mitochondria","criteria":"significantly different from control (p < 0.05)","result":true},{"rec_id":"RC04985","func":"F02010201","targ":null,"compound":"D0098: Pioglitazone","paper":"225","func_act":"","targ_act":"","dose":"10-50 μM","time":"","method":"OCR and measured using a fluorescent oxygen probe (Presens)","species":"ZDF fa/fa rat & ZDF lean rat","animal_model":"isolated liver mitochondria","criteria":"","result":false},{"rec_id":"RC04986","func":"F02010201","targ":null,"compound":"D0097: Phenformin","paper":"225","func_act":"","targ_act":"","dose":"30-300 μM","time":"","method":"OCR and measured using a fluorescent oxygen probe (Presens)","species":"ZDF fa/fa rat & ZDF lean rat","animal_model":"isolated liver mitochondria","criteria":"","result":false},{"rec_id":"RC04987","func":"F02010201","targ":null,"compound":"D0097: Phenformin","paper":"225","func_act":"","targ_act":"","dose":"30-300 μM","time":"","method":"OCR and measured using a fluorescent oxygen probe (Presens)","species":"ZDF fa/fa rat & ZDF lean rat","animal_model":"isolated liver mitochondria","criteria":"","result":false},{"rec_id":"RC04988","func":"F022101","targ":null,"compound":"D0124: Troglitazone","paper":"225","func_act":"lower","targ_act":"","dose":"10 µM","time":"","method":"Measurement of reduced/oxidized glutathione (GSH/GSSG): the reduced/oxidized glutathione (GSH/GSSG) concentration of the samples was determined from a standard curve using the enzymatic method and a Multiskan JX system.","species":"ZDF fa/fa rat vs ZDF lean rat","animal_model":"isolated mitochondria","criteria":"significantly different from ZDF lean rats (p < 0.05).","result":true},{"rec_id":"RC04989","func":"F022101","targ":null,"compound":"D0124: Troglitazone","paper":"225","func_act":"lower","targ_act":"","dose":"10 µM","time":"","method":"Measurement of reduced/oxidized glutathione (GSH/GSSG): the reduced/oxidized glutathione (GSH/GSSG) concentration of the samples was determined from a standard curve using the enzymatic method and a Multiskan JX system.","species":"ZDF fa/fa rat vs ZDF lean rat","animal_model":"liver homogenate","criteria":"","result":false},{"rec_id":"RC04990","func":"F020603","targ":null,"compound":"D0124: Troglitazone","paper":"225","func_act":"","targ_act":"","dose":"10 µM","time":"","method":"lipid peroxidation was measured from thiobarbituric acid-reactive substances (TBARS) formation  at 480-570 nm.","species":"ZDF fa/fa rat vs ZDF lean rat","animal_model":"isolated mitochondria and liver homogenates","criteria":"","result":false},{"rec_id":"RC04991","func":"F020605","targ":null,"compound":"D0124: Troglitazone","paper":"225","func_act":"peroxidation","targ_act":"","dose":"10 µM","time":"","method":"Oxidation of mitochondrial phospholipids was measured by HPLC analysis. Peak area ratio (235/206 nm) shows relative peroxidative phospholipid content. Peak areas at 206 nm and 235 nm analyze non-peroxidative and peroxidative phospholipid.","species":"ZDF fa/fa rat vs ZDF lean rat","animal_model":"isolated mitochondria","criteria":"significantly different from ZDF lean rats (p < 0.05)","result":true},{"rec_id":"RC04992","func":"F0303","targ":null,"compound":"D0124: Troglitazone","paper":"225","func_act":"increase","targ_act":"","dose":"10 µM","time":"","method":"Measurement of MPT using vesicle-fused mitochondria (  isolated mitochondria were preincubated with micellized phospholipid containing CL or CLOOH,and then a swelling assay was performed. )","species":"Wistar rat","animal_model":"Isolated rat liver mitochondria","criteria":"","result":true},{"rec_id":"RC04993","func":"F030602","targ":null,"compound":"D0124: Troglitazone","paper":"332","func_act":"abnormal","targ_act":"","dose":"25 µM","time":"","method":"Images from transmission  electron  microscopy  ","species":"","animal_model":"HepG2 cells","criteria":"","result":true},{"rec_id":"RC04994","func":"F0303","targ":null,"compound":"D0124: Troglitazone","paper":"332","func_act":"","targ_act":"","dose":"25 µM","time":"","method":"confocal laser scanning microscopy (MitoTracker Red)","species":"","animal_model":"HepG2 cells","criteria":"","result":true},{"rec_id":"RC04995","func":"F01","targ":null,"compound":"D0124: Troglitazone","paper":"332","func_act":"decrease","targ_act":"","dose":">25 µM","time":"30min","method":"JC1","species":"","animal_model":"HepG2 cells","criteria":"","result":true},{"rec_id":"RC04996","func":"F021203","targ":null,"compound":"D0124: Troglitazone","paper":"332","func_act":"decrease","targ_act":"","dose":">25 µM","time":"1 and 2 hr","method":"Cellular ATP concentrations were measured with a ATP Bioluminescent Somatic Cell Assay Kit","species":"","animal_model":"HepG2 cells","criteria":"","result":true},{"rec_id":"RC04997","func":"F01","targ":null,"compound":"D0124: Troglitazone","paper":"330","func_act":"decrease","targ_act":"","dose":"100 µM","time":"5min","method":"Tetramethylrhodamine methyl ester (TMRE)","species":"","animal_model":"HepG2 cells","criteria":"","result":true},{"rec_id":"RC04998","func":"F01","targ":null,"compound":"D0124: Troglitazone","paper":"330","func_act":"decrease","targ_act":"","dose":" 61.9 µM","time":"3hr","method":"stained with a Mitotracker red dye, and then  fixed  with  paraformaldehyde","species":"","animal_model":"HepG2 cells","criteria":"IC50","result":true},{"rec_id":"RC04999","func":"F070104","targ":"T409","compound":"D0124: Troglitazone","paper":"330","func_act":"","targ_act":"activation","dose":"100 µM","time":"24hr","method":"Apo-One homogeneous caspase 3 assay kit","species":"","animal_model":"HepG2 cells","criteria":"","result":true},{"rec_id":"RC05000","func":null,"targ":"T021001","compound":"D1479: aminocarnitine","paper":"333","func_act":"","targ_act":"inhibition","dose":"76.4/27.3","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05001","func":null,"targ":"T021001","compound":"D1480: palmitoylaminocarnitine","paper":"333","func_act":"","targ_act":"inhibition","dose":"2.67/−","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05002","func":null,"targ":"T021001","compound":"D1481: ST1326","paper":"333","func_act":"","targ_act":"inhibition","dose":"1.05/1.45","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05003","func":null,"targ":"T021001","compound":"D1482: ST2425","paper":"333","func_act":"","targ_act":"inhibition","dose":"1.70/−","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05004","func":null,"targ":"T021001","compound":"D0302: Trimetazidine","paper":"333","func_act":"","targ_act":"inhibition","dose":">100/−","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":false},{"rec_id":"RC05005","func":null,"targ":"T021001","compound":"D0096: Perhexiline","paper":"333","func_act":"","targ_act":"inhibition","dose":">100/−","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":false},{"rec_id":"RC05006","func":null,"targ":"T021001","compound":"D0005: Amiodarone","paper":"333","func_act":"","targ_act":"inhibition","dose":">100/−","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":false},{"rec_id":"RC05007","func":null,"targ":"T021001","compound":"D0290: Oxfenicine","paper":"333","func_act":"","targ_act":"inhibition","dose":">100/−","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":false},{"rec_id":"RC05008","func":null,"targ":"T021001","compound":"D1483: oxfenicine metabolite","paper":"333","func_act":"","targ_act":"inhibition","dose":">100/−","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":false},{"rec_id":"RC05009","func":null,"targ":"T021001","compound":"D1484: RO-25-0187","paper":"333","func_act":"","targ_act":"inhibition","dose":"2.4/−","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05010","func":null,"targ":"T021002","compound":"D1479: aminocarnitine","paper":"333","func_act":"","targ_act":"inhibition","dose":">100","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":false},{"rec_id":"RC05011","func":null,"targ":"T021002","compound":"D1480: palmitoylaminocarnitine","paper":"333","func_act":"","targ_act":"inhibition","dose":"21.7","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05012","func":null,"targ":"T021002","compound":"D1481: ST1326","paper":"333","func_act":"","targ_act":"inhibition","dose":"5.4","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05013","func":null,"targ":"T021002","compound":"D1482: ST2425","paper":"333","func_act":"","targ_act":"inhibition","dose":"85.3","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05014","func":null,"targ":"T021002","compound":"D0302: Trimetazidine","paper":"333","func_act":"","targ_act":"inhibition","dose":">100","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":false},{"rec_id":"RC05015","func":null,"targ":"T021002","compound":"D0096: Perhexiline","paper":"333","func_act":"","targ_act":"inhibition","dose":">100","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":false},{"rec_id":"RC05016","func":null,"targ":"T021002","compound":"D0005: Amiodarone","paper":"333","func_act":"","targ_act":"inhibition","dose":">100","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":false},{"rec_id":"RC05017","func":null,"targ":"T021002","compound":"D0290: Oxfenicine","paper":"333","func_act":"","targ_act":"inhibition","dose":">100","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":false},{"rec_id":"RC05018","func":null,"targ":"T021002","compound":"D1483: oxfenicine metabolite","paper":"333","func_act":"","targ_act":"inhibition","dose":"60.3","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05019","func":null,"targ":"T021002","compound":"D1484: RO-25-0187","paper":"333","func_act":"","targ_act":"inhibition","dose":"0.16","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05020","func":null,"targ":"T022","compound":"D1479: aminocarnitine","paper":"333","func_act":"","targ_act":"inhibition","dose":"3.9/5.1","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05021","func":null,"targ":"T022","compound":"D1480: palmitoylaminocarnitine","paper":"333","func_act":"","targ_act":"inhibition","dose":"0.14","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05022","func":null,"targ":"T022","compound":"D1481: ST1326","paper":"333","func_act":"","targ_act":"inhibition","dose":"0.16/0.38","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05023","func":null,"targ":"T022","compound":"D1482: ST2425","paper":"333","func_act":"","targ_act":"inhibition","dose":"5.4/−","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05024","func":null,"targ":"T022","compound":"D0302: Trimetazidine","paper":"333","func_act":"","targ_act":"inhibition","dose":">100/−","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":false},{"rec_id":"RC05025","func":null,"targ":"T022","compound":"D0096: Perhexiline","paper":"333","func_act":"","targ_act":"inhibition","dose":"72.8/−","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05026","func":null,"targ":"T022","compound":"D0005: Amiodarone","paper":"333","func_act":"","targ_act":"inhibition","dose":">100/−","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":false},{"rec_id":"RC05027","func":null,"targ":"T022","compound":"D0290: Oxfenicine","paper":"333","func_act":"","targ_act":"inhibition","dose":">100/−","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":false},{"rec_id":"RC05028","func":null,"targ":"T022","compound":"D1483: oxfenicine metabolite","paper":"333","func_act":"","targ_act":"inhibition","dose":">100/−","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":false},{"rec_id":"RC05029","func":null,"targ":"T022","compound":"D1484: RO-25-0187","paper":"333","func_act":"","targ_act":"inhibition","dose":"4.7/>100","time":"","method":"spectrophotometric assay with DTNB","species":"human/rat","animal_model":"recombinant Pichia pastoris Membrane Preparations ","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05030","func":"F02060201","targ":null,"compound":"D1485: TDGA","paper":"333","func_act":"inhibition","targ_act":"","dose":"0.31","time":"","method":"ketone bodies (KB = β-hydroxybutyrate + acetoacetate) were determined with a commercially available kit (Autokit 3-HB from Wako)","species":"Wistar rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05031","func":"F02060201","targ":null,"compound":"D1486: POCA","paper":"333","func_act":"inhibition","targ_act":"","dose":"59.7","time":"","method":"ketone bodies (KB = β-hydroxybutyrate + acetoacetate) were determined with a commercially available kit (Autokit 3-HB from Wako)","species":"Wistar rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05032","func":"F02060201","targ":null,"compound":"D0264: Etomoxir","paper":"333","func_act":"inhibition","targ_act":"","dose":"2.76","time":"","method":"ketone bodies (KB = β-hydroxybutyrate + acetoacetate) were determined with a commercially available kit (Autokit 3-HB from Wako)","species":"Wistar rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05033","func":"F02060201","targ":null,"compound":"D1487: DET","paper":"333","func_act":"inhibition","targ_act":"","dose":"5.6","time":"","method":"ketone bodies (KB = β-hydroxybutyrate + acetoacetate) were determined with a commercially available kit (Autokit 3-HB from Wako)","species":"Wistar rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05034","func":"F02060201","targ":null,"compound":"D1479: aminocarnitine","paper":"333","func_act":"inhibition","targ_act":"","dose":"0.97","time":"","method":"ketone bodies (KB = β-hydroxybutyrate + acetoacetate) were determined with a commercially available kit (Autokit 3-HB from Wako)","species":"Wistar rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05035","func":"F02060201","targ":null,"compound":"D1480: palmitoylaminocarnitine","paper":"333","func_act":"inhibition","targ_act":"","dose":"0.11","time":"","method":"ketone bodies (KB = β-hydroxybutyrate + acetoacetate) were determined with a commercially available kit (Autokit 3-HB from Wako)","species":"Wistar rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05036","func":"F02060201","targ":null,"compound":"D1481: ST1326","paper":"333","func_act":"inhibition","targ_act":"","dose":"1.1","time":"","method":"ketone bodies (KB = β-hydroxybutyrate + acetoacetate) were determined with a commercially available kit (Autokit 3-HB from Wako)","species":"Wistar rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05037","func":"F02060201","targ":null,"compound":"D1482: ST2425","paper":"333","func_act":"inhibition","targ_act":"","dose":"0.21","time":"","method":"ketone bodies (KB = β-hydroxybutyrate + acetoacetate) were determined with a commercially available kit (Autokit 3-HB from Wako)","species":"Wistar rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05038","func":"F02060201","targ":null,"compound":"D0302: Trimetazidine","paper":"333","func_act":"inhibition","targ_act":"","dose":"47.1","time":"","method":"ketone bodies (KB = β-hydroxybutyrate + acetoacetate) were determined with a commercially available kit (Autokit 3-HB from Wako)","species":"Wistar rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05039","func":"F02060201","targ":null,"compound":"D0096: Perhexiline","paper":"333","func_act":"inhibition","targ_act":"","dose":"14.8","time":"","method":"ketone bodies (KB = β-hydroxybutyrate + acetoacetate) were determined with a commercially available kit (Autokit 3-HB from Wako)","species":"Wistar rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05040","func":"F02060201","targ":null,"compound":"D0005: Amiodarone","paper":"333","func_act":"inhibition","targ_act":"","dose":"16.6","time":"","method":"ketone bodies (KB = β-hydroxybutyrate + acetoacetate) were determined with a commercially available kit (Autokit 3-HB from Wako)","species":"Wistar rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05041","func":"F02060201","targ":null,"compound":"D0290: Oxfenicine","paper":"333","func_act":"inhibition","targ_act":"","dose":">100","time":"","method":"ketone bodies (KB = β-hydroxybutyrate + acetoacetate) were determined with a commercially available kit (Autokit 3-HB from Wako)","species":"Wistar rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05042","func":"F02060201","targ":null,"compound":"D1483: oxfenicine metabolite","paper":"333","func_act":"inhibition","targ_act":"","dose":"25.8","time":"","method":"ketone bodies (KB = β-hydroxybutyrate + acetoacetate) were determined with a commercially available kit (Autokit 3-HB from Wako)","species":"Wistar rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05043","func":"F02060201","targ":null,"compound":"D1484: RO-25-0187","paper":"333","func_act":"inhibition","targ_act":"","dose":"1.5","time":"","method":"ketone bodies (KB = β-hydroxybutyrate + acetoacetate) were determined with a commercially available kit (Autokit 3-HB from Wako)","species":"Wistar rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true},{"rec_id":"RC05044","func":"F02060101","targ":null,"compound":"D1485: TDGA","paper":"333","func_act":"inhibition","targ_act":"","dose":"<0.05/0.04","time":"","method":"Fatty acid oxidation (FAO) was determined by measuring 14CO2 release from 14C-labeled palmitate","species":"human/rat","animal_model":"hepatocytes","criteria":"IC50 (μM)","result":true}]}